Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06552702 · ClinicalTrials.gov registry record
Race and Socioeconomic Position: Examining Common Social Pathways to Disease Risk
A clinical trial, sponsored by University of Alabama, Tuscaloosa.
- Completed
- Registry status
- 32
- Enrollment target
NCT06552702: Completed study, sponsored by University of Alabama, Tuscaloosa.
NCT06552702 is a clinical trial that has completed, run by University of Alabama, Tuscaloosa. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06552702 has completed, sponsored by University of Alabama, Tuscaloosa.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Black Americans and those of lower socioeconomic position (SEP) are at higher risk for multiple diseases of aging and shorter lifespans, but the psychophysiological mechanisms that may account for these effects are not clear. The overarching objective of this pilot grant is to improve our understanding of the proximal social exposures and subsequent psychobiological processes that contribute to racial and socioeconomic health disparities. Precisely understanding what these mutable social and psychological mechanisms are is necessary in order to identify intervention targets at the level of the individual.
Primary Outcome
Mean
Interventions
- OTHER There is no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2022-12-16 |
What the finished NCT06552702 record still lists
NCT06552702 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention is the first listed.
NCT06552702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06552702 about?
NCT06552702 is a clinical study titled "Race and Socioeconomic Position: Examining Common Social Pathways to Disease Risk". Black Americans and those of lower socioeconomic position (SEP) are at higher risk for multiple diseases of aging and shorter lifespans, but the psychophysiological mechanisms that may account for these effects are not clear. The overarching objective of this pilot grant is to improve our understand...
What is the current status of trial NCT06552702?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2022-03-28. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT06552702?
The interventions under investigation include: There is no intervention (OTHER).
Who is sponsoring clinical trial NCT06552702?
This trial is sponsored by University of Alabama, Tuscaloosa, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI